DHR
Danaher Corp
DIAGNOSTICS & RESEARCH · HEALTHCARE
Danaher Corporation (DHR) is a leading American diversified conglomerate headquartered in Washington, D.C., with a strong focus on Life Sciences, Diagnostics, and Environmental and Applied Solutions. Renowned for its commitment to innovation and cutting-edge technology, Danaher plays a crucial role ...
$209.36
-0.08% ($0.16)
Volume
2.84M
52W High
$242.80
52W Low
$170.19
Market Cap
$133.67B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.94
Whisper EPS
$1.96
1.1% above consensus
Last Quarter
$2.23
Current Streak
2 Beats
Avg Surprise (4Q)
-7.68%
Next Earnings Report
Reports in 51 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Jan 28, 2026
1-Day:
-2.19%
5-Day:
-0.50%
Q3 2025
Oct 21, 2025
1-Day:
-1.21%
Q2 2025
Jul 22, 2025
1-Day:
+4.20%
Q1 2025
Apr 22, 2025
1-Day:
+2.21%
Revenue & Financial Performance
Revenue Whisper
$6.41B
TWN Proprietary Estimate
Last Quarter Revenue
$6.84B
+4.6% YoY
Gross Margin
58.0%
Net Margin: 17.5%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $6.84B | +4.6% | 58.0% | 22.0% | $1.20B |
| Q3'25 | $6.05B | +4.4% | 58.2% | 19.1% | $908.0M |
| Q2'25 | $5.94B | +3.4% | 66.6% | 20.1% | $555.0M |
| Q1'25 | $5.74B | -1.0% | 61.4% | 22.5% | $954.0M |
| Q4'24 | $6.54B | +2.1% | 59.5% | 26.7% | $1.09B |
| Q3'24 | $5.80B | +3.1% | 58.7% | 16.5% | $818.0M |
| Q2'24 | $5.74B | -19.8% | 59.7% | 20.3% | $907.0M |
| Q1'24 | $5.80B | -2.6% | 60.2% | 22.6% | $1.09B |
Company Information
Symbol
DHR
Company
Danaher Corp
Market Cap
$133.67B
Sector
HEALTHCARE
Next Earnings
Apr 21, 2026
Also Reporting Soon
Companies reporting earnings around the same time as DHR
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DIAGNOSTICS & RESEARCH
Compare DHR with competitors
Side-by-side earnings comparison